Gadaleta-Caldarola, G.; Lanotte, L.; Santoro, A.N.; Pinto, A.; Gadaleta-Caldarola, A.; Giacomelli, L.; Fedele, P.
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review. Cancers 2024, 16, 4082.
https://doi.org/10.3390/cancers16234082
AMA Style
Gadaleta-Caldarola G, Lanotte L, Santoro AN, Pinto A, Gadaleta-Caldarola A, Giacomelli L, Fedele P.
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review. Cancers. 2024; 16(23):4082.
https://doi.org/10.3390/cancers16234082
Chicago/Turabian Style
Gadaleta-Caldarola, Gennaro, Laura Lanotte, Anna Natalizia Santoro, Antonello Pinto, Arianna Gadaleta-Caldarola, Luca Giacomelli, and Palma Fedele.
2024. "Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review" Cancers 16, no. 23: 4082.
https://doi.org/10.3390/cancers16234082
APA Style
Gadaleta-Caldarola, G., Lanotte, L., Santoro, A. N., Pinto, A., Gadaleta-Caldarola, A., Giacomelli, L., & Fedele, P.
(2024). Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review. Cancers, 16(23), 4082.
https://doi.org/10.3390/cancers16234082